检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:喻哲明[1] 丁正同[1] 任惠民[1] 邬剑军[1] 王坚[1] 陈嬿[1]
出 处:《中国临床神经科学》2012年第3期241-246,共6页Chinese Journal of Clinical Neurosciences
基 金:国家自然科学基金资助项目(编号:30872723)
摘 要:目的:通过转染人α-突触核蛋白(α-syn)A53T突变基因的PC12细胞(A53T-PC12细胞)模型,探讨β-淀粉样蛋白1-42(Aβ1-42)对A53T-PC12细胞在Ser29位点α-syn磷酸化(Pα-syn)水平、聚集程度的影响。方法:分别予H2O2、PBS、Aβ1-42干预A53T-PC12细胞(将A53T-PC12细胞分为:PBS干预组;5μmol.L-1Aβ1-42干预组;5μmol.L-1Aβ1-42+300μmol.L-1维生素C干预组;200μmol.L-1H2O2干预组),观察细胞内活性氧自由基(ROS)水平变化。并通过双重免疫荧光染色观察A53T-PC12细胞内α-syn聚集情况,并通过Western blot半定量分析A53T-PC12细胞内Ser129位点磷酸化Pα-syn水平。结果:Aβ1-42增加细胞内ROS。免疫荧光染色提示Aβ1-42干预后促进A53T-PC12细胞内α-syn聚集;Western blot半定量分析显示Pα-syn较PBS干预组升高(P<0.001,P<0.05)。结论:Aβ1-42促进A53T-PC12细胞内α-syn在Ser129位点磷酸化和聚集。Aim: To explore the effect of amyloid-β1-42(Aβ1-42) on the phosphorylation and aggregation of α-synuclein(α-syn) at serine 129 site in A53T-PC12 cells,which were made from the PC12 cells transfected with human A53T mutant SNCA gene.Methods: Reactive oxygen species(ROS) in A53T-PC12 cells treated by H2O2,PBS,Aβ1-42,Aβ1-42+ vitamin C were detected,and the changes of α-syn aggregation were also detected by the double immunofluorescence dyeing,respectively.Then phosphorylated α-syn at serine 129(Pα-syn),the aggregation of α-syn were analyzed by Western blot.Results: The amount of ROS increased in A53TPC12 cells treated respectively with H2O2and Aβ1-42,while decreased in the cells treated with Aβ1-42+ vitamin C.Immunofluorescence showed that Aβ1-42promoted the aggregation of α-syn in A53T-PC12 cells.Compared with the PBS group,Aβ1-42 could significantly increase the relative amount of Pα-syn(P0.001) and α-syn aggregations(P0.05).Conclusion: Aβ1-42 could enhance α-syn phosphorylation at serine129 and promote aggregation of α-syn in A53T-PC12 cells.
关 键 词:β淀粉样蛋白1-42 α-突触核蛋白聚集 帕金森病 氧自由基
分 类 号:R742.5[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28